National Immunization Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Grim milestone tonight, 15,000. We are hearing details about a san jose woman who appears to be the nations first coronavirus victim. Reporter friends tell me they cant believe it. A southbay mother and wife who has now become the nations first covid19 death. That was 12 days earlier than the previous case. Patricia dowd of san jose was 57 years old when she died february 6th. This week, a new wave of grieving as many learned their friend tested positive after her death from covid19. ; was absolutely shocked, speechless. Reporter s be steve banner worked with her at research. Her linkedin page...

Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda's goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda's existing facility in Germany and its partnership with IDT Biologika GmbH.

Earlier in the decade, GSK was under attack by several hedge funds that believed the company was underperforming and following the wrong strategy.

GSK said, in the year to date, it has exceeded its full-year guidance expectations.

It looks like GSK may have found its blockbuster. Arexvy, the world’s first RSV vaccine for older adults has been approved in the U.S. and Japan.